14 Nov 2022 InnoCare Releases 2022 Third Quarter Results: Star Board Listing for Long-term Growth and Rapid Increase of Orelabrutinib Sales Press Releases BEIJING–(
14 Nov 2022 World-First Inhaled COVID-19 Vaccine, Developed in Partnership Between Aerogen® and CanSinoBIO, First Public Booster Immunization in China. Press Releases GALWAY, Ireland–(…
14 Nov 2022 Genentech Provides Update on Phase III GRADUATE Program Evaluating Gantenerumab in Early Alzheimer’s Disease Press Releases
14 Nov 2022 ENHERTU® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Advanced Gastric Cancer Press Releases
14 Nov 2022 Apollo Therapeutics and The Institute of Cancer Research enter into collaboration for cancer drug development Press Releases
14 Nov 2022 Kezar Life Sciences Presents Positive Complete Results from the MISSION Phase 2 Trial Evaluating Zetomipzomib in Lupus Nephritis at the American College of Rheumatology Convergence 2022 Press Releases
14 Nov 2022 Exscientia and MD Anderson Launch Strategic Collaboration to Leverage AI in Developing Novel Oncology Treatments Press Releases
14 Nov 2022 TriSalus Life Sciences to Become Publicly Traded Through Merger With MedTech Acquisition Corporation Press Releases DENVER & FORT LAUDERDALE, Fla…
14 Nov 2022 Infinity Pharmaceuticals Provides MARIO-3 Update in Patients with Front Line Metastatic Triple Negative Breast Cancer Suggesting Potential Long-Term Patient Benefit of Eganelisib Press Releases
14 Nov 2022 MyMD Pharmaceuticals Announces Publication of Phase 1 Data for oral TNF-alpha Inhibitor MYMD-1® in Peer-Reviewed Journal Drug Research Press Releases
